Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Die Innere Medizin
Erschienen in: Der Internist 6/2016

01.06.2016 | Schwerpunkt: Klug entscheiden

Gemeinsam mit dem Patienten klug entscheiden

verfasst von: Prof. Dr. Dr. h.c. U. R. Fölsch, G. Hasenfuß

Erschienen in: Die Innere Medizin | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Im Rahmen der Klug-entscheiden-Initiative der Deutschen Gesellschaft für Innere Medizin (DGIM) wurden die mit der Inneren Medizin assoziierten Fachgesellschaften gebeten, aus den jeweils 60 definierten Beispielen der Über- und Unterversorgung diejenigen zu benennen und hervorzuheben, die für die direkte Arzt-Patienten-Interaktion von unmittelbarer Relevanz sind. Dabei sind von den zwölf Fachgesellschaften jeweils zwei Empfehlungen erarbeitet und begründet worden. Somit ergibt sich ein Spektrum wichtiger Empfehlungen, das die gesamte Innere Medizin umfasst. Es soll dazu beitragen, das Gespräch mit dem Patienten in schwierigen Situationen auf wissenschaftlich gesicherte Erkenntnisse auszurichten.
Literatur
1.
Hasenfuß G, Fölsch UR (2016) Historie, Grundlagen und Mitgliederbefragung zu „Klug entscheiden“. Internist. doi:10.1007/s00108-016-0062-6
2.
Jung N, Berner R, Bogner J et al (2016) Klug entscheiden in der Infektiologie. Dtsch Ärztebl 113(13):510
3.
Feldkamp J, Schott M, Gogol M et al (2016) Empfehlungen der Deutschen Gesellschaft für Endokrinologie und der Deutschen Gesellschaft für Geriatrie. Internist. DOI 10.1007/s00108-016-0072-4PubMed
4.
Morden NE, Colla CH, Sequist TD et al (2014) Choosing wisely – the politics and economics of labelling low-value services. N Engl J Med 370:589–592PubMedPubMedCentralCrossRef
5.
Wolfson D, Santana J, Slass L (2014) Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med 89:990–995PubMedCrossRef
6.
7.
Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP (2014) Ultrasonography Screening for Abdominal Aortic Aneurysms: A Systematic Evidence Review for the U.S. Preventive ServicesTask Force. Ann Intern Med 160:321–329PubMedCrossRef
8.
Dabare D, Lo TTH, McCormack DJ, Kung VWS (2012) What is the role of screening in the management of abdominal aortic aneurysms? Interact Cardiovasc Thorac Surg 14:399–405PubMedPubMedCentralCrossRef
9.
Eckstein HH, Böckler D, Flessenkämper I, Schmitz-Rixen T, Debus S, Lang W (2009) Ultraschall-Screening abdominaler Aortenaneurysmen. Dtsch Arztebl Int 106(41):657–663. doi:10.3238/arztebl.2009.0657PubMedPubMedCentral
10.
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Ultraschall-Screening auf Bauchaortenaneurysmen. IQWiG-Berichte – Nr. 294.
11.
Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175–179PubMedCrossRef
12.
Lunt M, O’Neill TW, Felsenberg D, Reeve J, Kanis JA, Cooper C et al (2003) Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). Bone 33(4):505–513PubMedCrossRef
13.
Reeve J, Lunt M, Felsenberg D, Silman AJ, Scheidt-Nave C, Poor G et al (2003) European Prospective Osteoporosis Study Group. Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 18(9):1664–1673PubMedCrossRef
14.
Cauley JA, Hochberg MC, Lui LY, Palermo L, Ensrud KE, Hillier TA et al (2007) Long-term risk of incident vertebral fractures. JAMA 298(23):2761–2767PubMedCrossRef
15.
Colon-Emeric C, Kuchibhatla M, Pieper C, Hawkes W, Fredman L, Magaziner J et al (2003) The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 14(11):879–883PubMedCrossRef
16.
Prophylaxe, Diagnostik und Therapie der Osteoprose bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V.
17.
18.
19.
20.
Nationale Versorgungsleitlinie Diabetes: Strukturierte Schulungsprogramme, Langfassung 1. Auflage, Version 3, Dezember 2012, Zuletzt geändert: Juni 2013 AWMF-Reg.-Nr.: nvl/001 f.
21.
Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 2013(122):872–884CrossRef
22.
Shaw A, Kim D, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O’Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Jänne PA (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385–2394PubMedCrossRef
23.
Chapman P, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O’Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, BRIM-3 Study Group (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507–2516PubMedPubMedCentralCrossRef
24.
Allegra C, Jessup J, Somerfield M, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL (2009) American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27(12):2091–2096PubMedCrossRef
25.
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Saad AA, Sokol L, Swinnen LJ, Tsien C, Vose JM, Wilson L, Yahalom J, Zafar N, Dwyer M, Sundar H (2015) National comprehension cancer network. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1. J Natl Compr Canc Netw 2015(13):326–362
26.
Bödeker et al (2015) Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health 15:1–10CrossRef
27.
Uyeki TM (2014) Preventing and controlling influenza with available interventions. N Engl J Med 370:789–791PubMedCrossRef
28.
Ständigen Impfkommission (STIKO) am Robert Koch-Institut (2015) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 34:327–362
29.
30.
31.
32.
Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Dtsch Arztebl 108(A):346–348
33.
34.
Bosslet GT, Pope TM, Rubenfeld GD et al (2015) An official ATS/AACN/ACCP/ESICM/SCCM policy statement: responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med 191:1318–1330PubMedCrossRef
35.
Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V (2015) Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 14(4):377–387PubMedCrossRef
36.
Hart RG, Pearce LA, Aguilar MI (2007) Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med 147(8):590PubMedCrossRef
37.
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–47
38.
Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP (2014) Real-world‘ antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med 127(6):519–529PubMedCrossRef
39.
Hug JI, Clair C, Hug B, Rodondi N, Waeber G, Cornuz J, Aujesky D (2012) Risk of falls and major bleeds in patients on oral anticoagulation therapy. Am J Med 125(8):773–778PubMedCrossRef
40.
Kauz A, Pahari D (2004) The value of vaccination in chronic kidney disease. Semin Dial 17:9–11CrossRef
41.
42.
43.
44.
45.
46.
47.
48.
Andreas S, Batra A, Behr J, Chenot JF, Gillissen A, Hering T, Herth FJF, Kreuter M, Meierjürgen R, Mühlig S, Nowak D, Pfeifer M, Raupach T, Schultz K, Sitter H, Walther JW, Worth H (2014) Tabakentwöhnung bei COPD. S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 68:237–258
49.
Jimenez-Ruiz CA, Andreas S, Lewis KE et al (2015) Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J 46:61–79PubMedCrossRef
50.
Anthonisen NR, Skeans MA, Wise RA et al (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142:233–239PubMedCrossRef
51.
Paone G, Serpilli M, Girardi E, Conti V, Principe R, Puglisi G, De Marchis L, Schmid G (2008) The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate. J Rehabil Med 40:672–677. doi:10.2340/16501977-0234PubMedCrossRef
52.
Preiss JC, Bokemeyer B, Buhr HJ, Dignass A, Hauser W, Hartmann F et al (2014) Updated German clinical practice guideline on “Diagnosis and treatment of Crohn’s disease” 2014. Z Gastroenterol 52(12):1431–1484PubMedCrossRef
53.
Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81(11):1462–1471PubMedCrossRef
54.
Timmer A, Sutherland LR, Martin F (1998) Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. the canadian Mesalamine for remission of Crohn’s disease study group. Gastroenterology 114(6):1143–1150PubMedCrossRef
55.
Kane SV, Flicker M, Katz-Nelson F (2005) Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J Clin Gastroenterol 39(1):32–35PubMed
56.
Johnson GJ, Cosnes J, Mansfield JC (2005) Review article: smoking cessation as primary therapy to modify the course of Crohn’s disease. Aliment Pharmacol Ther 21(8):921–931PubMedCrossRef
57.
Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterol 110(2):424–431CrossRef
58.
Andreas S, Batra A, Behr J, Chenot JF, Gillissen A, Hering T et al (2014) Smoking cessation in patients with COPD. Pneumol 68(4):237–258CrossRef
59.
Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK), AWMF-Register-Nr. 065/003.
60.
Cao P, Eckstein HH, De Rango P et al (2011) Critical limb ischemia. Chapter II: Diagnostic Methods. Eur J Vasc Endovascular Surg 42(S2):S13–S32CrossRef
61.
Chan D, Anderson ME, Dolmatch BL (2010) Imaging evaluation of lower extremity infrainguinal disease: role of the noninvasive vascular laboratory, computed tomography angiography, and magnetic resonance angiography. Tech Vasc Interv Radiol 13:11–22PubMedCrossRef
62.
Finucane TE, Christmas C, Travis K (1999) Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 282:1365–1370PubMedCrossRef
63.
Gabriel SE, Normand ST (2012) Getting the methods right – the foundation of patient-centered outcomes research. N Engl J Med 367:787–790PubMedCrossRef
64.
Teno JM, Feng Z, Mitchell SL, Kuo S, Intrator O, Mor V (2008) Do financial incentives of introducing case mix reimbursement increase feeding tube use in nursing home residents? J Am Geriatr Soc 56:887–890PubMedPubMedCentralCrossRef
65.
Teno JM, Mitchell SL, Kuo SK, Gozalo PL, Rhodes RL et al (2011) Decision-making and outcomes of feeding tube insertion: a five-state study. J Am Geriatr Soc 59:881–886PubMedPubMedCentralCrossRef
66.
Palecek EJ, Teno JM, Casarett DJ, Hanson LC, Rhodes RL, Mitchell SL (2010) Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 58:580–584PubMedPubMedCentralCrossRef
67.
Hanson LC, Carey TS, Caprio AJ, Lee TJ, Ersek M et al (2011) Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatr Soc 59:2009–2016PubMedPubMedCentralCrossRef
68.
Teno JM, Gozalo PL, Mitchell SL, Kuo S, Rhodes RL et al (2012) Does feeding tube insertion and its timing improve survival? J Am Geriatr Soc 60:1918–1921PubMedPubMedCentralCrossRef
69.
Hanson LC, Ersek M, Gilliam R, Carey TS (2011) Oral feeding options for people with dementia: a systematic review. J Am Geriatr Soc 59:463–472PubMedPubMedCentralCrossRef
70.
Sorrell JM (2010) Use of feeding tubes in patients with advanced dementia: are we doing harm? J Psychosoc Nurs Ment Health Serv 48:15–18
71.
Sampson EL, Candy B, Jones L (2009) Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev 2:CD007209PubMed
72.
Gillick MR, Volandes AE (2008) The standard of caring: why do we still use feeding tubes in patients with advanced dementia? J Am Med Dir Assoc 9:364–367PubMedCrossRef
73.
Ganzini L (2006) Artificial nutrition and hydration at the end of life: ethics and evidence. Palliat Support Care 4:135–143PubMedCrossRef
74.
Li I (2002) Feeding tubes in patients with severe dementia. Am Fam Physician 65:1605–1611PubMed
75.
Mitchell SL, Kiely DK, Lipsitz LA (1997) The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 157:327–332PubMedCrossRef
76.
Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G et al (2011) Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam or diazepam in older adults. J Am Geriatr Soc 59:1883–1890PubMedCrossRef
77.
Allain H, Bentue-Ferrer D, Polard E, Akwa Y, Patat A (2005) Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 22:749–765PubMedCrossRef
78.
American Geriatrics Society (2015) Beers criteria update expert panel. american geriatrics society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. doi:10.1111/jgs.13702
79.
Kripke DF, Langer RD, Kline LE (2012) Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ 2:e000850
80.
Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331:1169PubMedPubMedCentralCrossRef
81.
Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE et al (2006) Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 295:2851–2858PubMedCrossRef
82.
Hanlon JT, Semla TP, Schmader KE (2015) Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. doi:10.1111/jgs.13807
83.
Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367:1616–1625PubMedPubMedCentralCrossRef
84.
Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N (2003) A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 327:195–198PubMedPubMedCentralCrossRef
85.
Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315–321PubMedCrossRef
86.
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK (2015) Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA Oncol 1:778–784PubMedCrossRef
87.
Azzoli CG, Temin S, Aliff T et al (2011) 2011 focused update of 2009 American Society of Oncology clinical practice guideline update on chemotherapy for stage IV non-small cell lung cance. J Clin Oncol 29:3825–3831PubMedPubMedCentralCrossRef
88.
Ettinger DS, Akerley W, Bepler G et al (2010) Non-small cell lung cancer. J Natl Compr Canc Netw 8:740–801PubMed
89.
Carlson RW, Allred DC, Anderson BO et al (2009) Breast cancer. J Natl Compr Canc Netw 7:122–192PubMed
90.
Engstrom PF, Benson AB 3rd, Chen YJ et al (2005) Colon cancer clinical practice guidelines. J Natl Compr Canc Netw 3:468–491PubMed
91.
92.
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730PubMedCrossRef
93.
Gaertner J, Wolf J, Voltz R (2012) Early palliative care for patients with metastatic cancer. Curr Opin Oncol 24:357–362PubMedCrossRef
94.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef
95.
Shapiro DJ et al (2014) Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J Antimicrob Chemother 69:234–240PubMedCrossRef
96.
97.
Little P et al (2013) Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 13:123–129PubMedCrossRef
98.
Hersh AL, American Academy of Pediatrics Committee on Infectious Diseases. (2013) Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 132:1146–1154PubMedCrossRef
99.
S3 Leitlinie DEGAM-Nr. 11. Husten (2014).
100.
Dellinger RP, Levy MM, Rhodes A et al (2012) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2013(41):580–637
101.
102.
Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G et al (2010) Selection criteria for drug versus bare-metal stents and the impact of routine angiographic follow-up: 2‑year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 56:1597–1604PubMedCrossRef
103.
Pinto DS, Stone GW, Ellis SG, Cox DA et al (2006) Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents. Results from the TAXUS-IV Trial. J Am Coll Cardiol 48:32–36PubMedCrossRef
104.
Uchida T, Popma J, Stone GW et al (2010) The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of “oculostenotic” reintervention in patients with intermediate lesions. JACC Cardiovasc Interv 3:403–411PubMedCrossRef
105.
Cassese S, Byrne RA, Schulz S, Hoppman P et al (2015) Prognostic role of restenosis in 10004 patients undergoing routine control angiography after coronary stenting. Eur Heart J 36:94–99PubMedCrossRef
106.
Bonzel T, Hamm CW, Albrecht A, Erbel R, Kelm M, Lange H, Levenson B, Neumann FJ, Rupprecht HJ, Schächinger V, Terres W, Voelker W, Zahn R (2009) Leitfaden Herzkatheter. Steinkopff, DarmstadtCrossRef
107.
Rassaf T, Steiner S, Kelm M (2013) Postoperative care and Follow-Up After Coronary Stenting. Dtsch Arztebl Int 110(5):72–82PubMedPubMedCentral
108.
Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541–2619.
109.
Levine GN, Bates ER, Blankenship JC, Bailey SR et al (2011) 2011 ACCF/AHA/SCAI guideline for Percutaneous coronary intervention: a report of the american college of cardiology foundation/american heart association task force on practice guidelines and the society for cardiovascular Angiography and interventions. Circulation 124:e574–e651PubMedCrossRef
110.
Palmer SC, Wong G, Iff S, Yang J, Jayaswal V, Craig JC, Rochtchina E, Mitchell P, Wang JJ, Strippoli GF (2014) Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: a population-based longitudinal cohort study. Nephrol Dial Transplant 29(7):1377–1384PubMedCrossRef
111.
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD (2011) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 6(5):966–967PubMedPubMedCentralCrossRef
112.
Payen D, Pont AC de, Sakr Y, Spies C, Reinhart K, Vincent JL (2008) Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 12(3):R74PubMedPubMedCentralCrossRef
113.
Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL (2009) Program to improve care in acute renal disease (PICARD) study group. fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76(4):422PubMedCrossRef
114.
Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM, Wollinset DA (2012) American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology. J Clin Oncol 30(14):1715–1724PubMedCrossRef
115.
Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung Präambel. Dtsch Arztebl 108(7):A346–A348
116.
Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409PubMedCrossRef
117.
Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22):2418–2429PubMedPubMedCentralCrossRef
118.
Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, Spaggiari L (2012) Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 157(11):776–784PubMedCrossRef
119.
Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 159(6):411–420PubMedCrossRef
120.
Herth FJF, Hoffmann H, Heussel CP (2014) Lungenkrebs-Screening – Update 2014. Pneumologie 68:781–783PubMedCrossRef
121.
Nationale Versorgungsleitlinie (NVL) Kreuzschmerz, Kurzfassung, Version 1.2.
122.
Auwarter PG, Bakken JS, Dattwyler RS et al (2011) Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis 11:713–719CrossRef
123.
Stanek G, Fingerle V, Hunfeld KP et al (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe (European Union Concerted Action on LB). Clin Microbiol Infect 17:69–79PubMedCrossRef
124.
Sigal LH (2011) Musculoskeletal features of Lyme disease: understanding the pathogenesis of clinical findings helps make appropriate therapeutic choices. J Clin Rheumatol 17:256–265PubMedCrossRef
125.
Feder HM, Johnson BJB, O’Connell S et al (2007) A critical appraisal of “Chronic Lyme Disease”. N Engl J med 357:1422–1430PubMedCrossRef
126.
Preiß JC, Bokemeyer B, Buhr HJ et al (2014) Aktualisierte S3-Leitlinie Diagnostik und Therapie des Morbus Crohn. Z Gastroenterol 52:1431–1484
127.
Dignass A, Preiß JC, Aust DE et al (2011) Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa. Z Gastroenterol 49:1276–1341
128.
Steinhart AH, Ewe K, Griffiths AM et al (2003) Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000301PubMed
129.
Lindgren S, Lofberg R, Bergholm L et al (2002) Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol 37:705–710PubMedCrossRef
130.
Meyers S, Lerer PK, Feuer EJ et al (1987) Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 9:50–54PubMedCrossRef
131.
Lichtenstein GR, Feagan BG, Cohen RD et al (2012) Serious infection and mortality in patients with Crohn’s disease: more than 5 years of followup in the TREAT registry. Am J Gastroenterol 107:1409–1422PubMedPubMedCentralCrossRef
132.
Fölsch UR, Faulbaum F, Hasenfuß G (2016) Klug entscheiden - Initiative. Eine Mitgliederbefragung der Deutschen Gesellschaft für Innere Medizin. Dtsch Arztebl 113(13):604
Metadaten
Titel
Gemeinsam mit dem Patienten klug entscheiden
verfasst von
Prof. Dr. Dr. h.c. U. R. Fölsch
G. Hasenfuß
Publikationsdatum
01.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Innere Medizin / Ausgabe 6/2016
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-016-0069-z

Weitere Artikel der Ausgabe 6/2016

Der Internist 6/2016 Zur Ausgabe

Mitteilungen des BDI

Mitteilungen des BDI

Schwerpunkt: Klug entscheiden

Klug entscheiden in der Inneren Medizin

Mitteilungen der DGIM

Mitteilungen der DGIM

Kasuistiken

Hirnstamminfarkt, temporaler Kopfschmerz & erhöhte Entzündungsparameter

Erratum

Erratum zu: Standardtherapie der Tuberkulose

Mitteilungen des BDI

Mitteilungen des BDI

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise